New drug trial aims to halt rapid nerve damage in GBS

NCT ID NCT07020819

Recruiting now Disease control Sponsor: Annexon, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing a single dose of an investigational drug called tanruprubart (ANX005) in people recently diagnosed with Guillain-Barré syndrome (GBS). The main goals are to see how the drug behaves in the body, if it is safe, and to look for early signs that it might help control the disease. It is enrolling about 30 adults and children in the US, Canada, and Europe who are within 10 days of their first GBS weakness.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Aarhus University Hospital
RECRUITING

Aarhus, Aarhus N, 8200, Denmark
Children's Hospital of Orange County
RECRUITING

Orange, California, 92868, United States
Henry Ford Health
RECRUITING

Detroit, Michigan, 48202, United States
HonorHealth Bob Bové Neuroscience Institute
RECRUITING

Scottsdale, Arizona, 85251, United States
Mayo Rochester
RECRUITING

Rochester, Minnesota, 55905, United States
Ochsner LSU Health
RECRUITING

Shreveport, Louisiana, 71101, United States
University Massachusetts Chan Medical School
RECRUITING

Worcester, Massachusetts, 01655, United States
University of California Irvine
RECRUITING

Orange, California, 92868, United States
University of Colorado Hospital
RECRUITING

Aurora, Colorado, 80045, United States

Conditions

Explore the condition pages connected to this study.

GUILLAIN-BARRE SYNDROME